Recursion Pharmaceuticals Inc

RXRXNASDAQ · US

Holders

ACQUIREDT+7
Hershberg Robert
Recursion Pharmaceuticals Inc · NASDAQ
+25,000 sh · $55.5K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Hershberg Robert
Recursion Pharmaceuticals Inc · NASDAQ
−25,000 sh · $125.0K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Borgeson Blake
Recursion Pharmaceuticals Inc · NASDAQ
−50,000 sh · $242.0K
Filed 7 Oct 2026SEC Form 4view source
ACQUIREDT+30
Dar Zavain
Recursion Pharmaceuticals Inc · NASDAQ
+4,607 sh
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
Taylor Ben R
Recursion Pharmaceuticals Inc · NASDAQ
−5,396 sh · $18.4K
Filed 16 Sept 2026SEC Form 4view source
REDUCEDStale
Khan Najat
Recursion Pharmaceuticals Inc · NASDAQ
−22,408 sh · $78.8K
Filed 10 Sept 2026SEC Form 4view source
REDUCEDStale
Borgeson Blake
Recursion Pharmaceuticals Inc · NASDAQ
−30,000 sh · $100.2K
Filed 2 Sept 2026SEC Form 4view source
DISCLOSEDQuarterly
ARK Investment Management
Recursion Pharmaceuticals Inc · NASDAQ
41,337,632 sh · $151.7M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Recursion Pharmaceuticals Inc · NASDAQ
2,400,605 sh · $7.4M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
ARK Investment Management
Recursion Pharmaceuticals Inc · NASDAQ
40,212,769 sh · $123.5M
Filed 31 Mar 2026SEC 13Fview source